Cargando…
Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739720/ https://www.ncbi.nlm.nih.gov/pubmed/29290935 http://dx.doi.org/10.18632/oncotarget.22580 |
| _version_ | 1783287924158103552 |
|---|---|
| author | Vidula, Neelima Bardia, Aditya |
| author_facet | Vidula, Neelima Bardia, Aditya |
| author_sort | Vidula, Neelima |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5739720 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57397202017-12-29 Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology Vidula, Neelima Bardia, Aditya Oncotarget Editorial Impact Journals LLC 2017-11-21 /pmc/articles/PMC5739720/ /pubmed/29290935 http://dx.doi.org/10.18632/oncotarget.22580 Text en Copyright: © 2017 Vidula et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Vidula, Neelima Bardia, Aditya Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title | Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title_full | Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title_fullStr | Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title_full_unstemmed | Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title_short | Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology |
| title_sort | targeted therapy for metastatic triple negative breast cancer: the next frontier in precision oncology |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739720/ https://www.ncbi.nlm.nih.gov/pubmed/29290935 http://dx.doi.org/10.18632/oncotarget.22580 |
| work_keys_str_mv | AT vidulaneelima targetedtherapyformetastatictriplenegativebreastcancerthenextfrontierinprecisiononcology AT bardiaaditya targetedtherapyformetastatictriplenegativebreastcancerthenextfrontierinprecisiononcology |